Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06795386 · ClinicalTrials.gov registry record

Chronic Widespread Pain After Rapid Weight Loss in Non-Hispanic Black and Hispanic/Latino/a/x Adults

A clinical trial of Obesity and Bariatric Surgery Candidate, sponsored by New York University.

Recruiting
Registry status
60
Enrollment target
3
Study locations

NCT06795386: Recruiting study of Obesity and Bariatric Surgery Candidate, sponsored by New York University.

NCT06795386 is a study of Obesity and Bariatric Surgery Candidate that is actively recruiting participants, run by New York University. The registered enrollment target is 60 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (93% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06795386, a study of Obesity and Bariatric Surgery Candidate, is actively recruiting participants, sponsored by New York University.

RECRUITING
Registry status
60 participants
Enrollment target
3
Study locations

Study Summary

The goal of this observational study is to learn if surgical weight loss can improve chronic widespread pain in people living with higher BMI who self-identify as Hispanic/Latino ethnicity or non-Hispanic Black based on the United States census racial categories. The main questions the study aims to answer are: 1. Do pain at rest (primary outcome) and movement-evoked pain (secondary outcome) improve after bariatric surgery? 2. Do pain processing and joint function change after bariatric surgery? 3. Are pain processing and joint function associated with clinically significant pain change after surgical weight loss? Researchers will compare pain and function before and 6 months after bariatric surgery in a single cohort.

Primary Outcome

Participant-reported pain intensity at rest will be assessed post-surgery using the Numeric Pain Rating Scale (NPRS). The NPRS is an ordinal scale with scores ranging from 0-10. Zero is indicative of no pain and 10 indicates the worst pain imaginable.

Interventions

  • PROCEDURE Bariatric Surgery

Study Locations (3)

New York

  • NYU Steinhardt Arthur J. Nelson Laboratory - New York
  • New York City Health + Hospitals/Bellevue Hospital - New York
  • NYU CTSI Clinical Research Center - New York

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2023-10-09
Est. Completion 2028-03
New York University

83 total trials

What NCT06795386 shows while recruiting

NCT06795386 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (93% lower).

The record links to 3 conditions, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which Bariatric Surgery is the first listed.

NCT06795386 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT06795386 about?

NCT06795386 is a clinical study titled "Chronic Widespread Pain After Rapid Weight Loss in Non-Hispanic Black and Hispanic/Latino/a/x Adults". The goal of this observational study is to learn if surgical weight loss can improve chronic widespread pain in people living with higher BMI who self-identify as Hispanic/Latino ethnicity or non-Hispanic Black based on the United States census racial categories. The main questions the study aims to...

What is the current status of trial NCT06795386?

This trial is currently recruiting. The enrollment target is 60 participants. The study started on 2023-10-09. Estimated completion is 2028-03.

What conditions does trial NCT06795386 study?

This clinical trial studies the following conditions: Obesity, Bariatric Surgery Candidate, Chronic Pain, Widespread.

What interventions are being tested in trial NCT06795386?

The interventions under investigation include: Bariatric Surgery (PROCEDURE).

Who is sponsoring clinical trial NCT06795386?

This trial is sponsored by New York University, which has 83 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06795386 being conducted?

This trial has 3 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06795386's enrollment target sits among peer trials

60 642nd of 1053 higher than 374 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06795386, the US trial registry maintained by the National Library of Medicine. NCT06795386 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.